Form 4 for EW Edwards Lifesciences
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-16 · accession 0001225208-23-002133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-16 | 2023-02-16 | EW | STONE HEISZ LESLIE | Dir | S - Sale+OE | $76.82 | -9,671 | 27.5K | -26% | -$742.9K |
| D | 2023-02-16 | 2023-02-16 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $35.68 | +9,671 | 37.2K | +35% | +$345.1K |
| D | 2023-02-16 | 2023-02-16 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $0.00 | -9,671 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | S | D | 9,671 | $76.82 | 27,480 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $76.71 to $76.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-02-16 | M | A | 9,671 | $35.68 | 37,151 | D | — | — | |
| 3 | Derivative | Director Stock Option (Right to Acquire) | 2023-02-16 | M | D | 9,671 | $0.00 | 0 | D | $35.68 · 2017-07-14 to 2023-07-13 | 9,671 Common Stock |